Vaccine Information Statement (VIS) -- Recombinant Zoster (Shingles) Vaccine, RZV: What You Need to Know
This two-page Vaccine Information Statement (VIS) educates people about the recombinant vaccine for shingles (herpes zoster), which is caused by the varicella zoster virus, the same virus that causes chickenpox. It describes shingles symptoms and possible consequences, and discusses the use of the recombinant shingles vaccine to prevent shingles and reduce the likelihood of post-herpetic neuralgia (PHN). It identifies who is more likely to get shingles, provides a recommened dosage schedule for adults 50 and older, and clarifies who should not get the vaccine. The VIS describes risks and possible problems, and explains what to look for and what to do in the event of a severe allergic reaction. Contact information for National Vaccine Injury Compensation Program (VICP) is provided, along with tips for how people can learn more about the live shingles vaccine.
The English-language VIS was created by the Centers for Disease Control and Prevention (CDC) National Center for Immunization and Respiratory Diseases. The translations are provided by the Immunization Action Coalition (IAC) and its partner organizations.
The English language resource was created or reviewed by a medical professional for quality and accuracy.
A qualified translation company performed an independent review by a second translator, and a client advocate.